The earliest allosteric MAT2A inhibitors with reported efficacy were AG270 and IDE397, which have shown selective inhibition of MTAP-null colorectal cancer, pancreatic cancer, and other solid tumors [101,102]. This evidence concerns the gene MTAP and familial pancreatic carcinoma.